血管内超声指导冠状动脉左主干介入治疗

doi:10.16138/j.1673-6087.2021.03.004

摘要/Abstract

关键词: 血管内超声, 冠状动脉左主干病变, 血流储备分数, 血运重建, 经皮冠状动脉介入治疗

中图分类号:

R543
R445

钱杰. 血管内超声指导冠状动脉左主干介入治疗[J]. 内科理论与实践, 2021, 16(03): 155-160.

参考文献 43

[1]	Giannoglou GD, Antoniadis AP, Chatzizisis YS, et al. Prevalence of narrowing >or=50% of the left main coronary artery among 17,300 patients having coronary angiography[J]. Am J Cardiol, 2006, 98(9): 1202-1205. doi: 10.1016/j.amjcard.2006.05.052 pmid: 17056328
[2]	Taylor HA, Deumite NJ, Chaitman BR, et al. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry[J]. Circulation, 1989, 79(6): 1171-1179. doi: 10.1161/01.cir.79.6.1171 pmid: 2785870
[3]	Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial[J]. Lancet, 2013, 381(9867): 629-638. doi: 10.1016/S0140-6736(13)60141-5 URL
[4]	Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease[J]. N Engl J Med, 2016, 375(23): 2223-2235. doi: 10.1056/NEJMoa1610227 URL
[5]	Lindstaedt M, Spiecker M, Perings C, et al. How good are experienced interventional cardiologists at predicting the functional significance of intermediate or equivocal left main coronary artery stenoses?[J]. Int J Cardiol, 2007, 120(2): 254-261. pmid: 17346818
[6]	Abizaid AS, Mintz GS, Abizaid A, et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms[J]. J Am Coll Cardiol, 1999, 34(3): 707-715. pmid: 10483951
[7]	Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394 URL
[8]	Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial[J]. Eur Heart J, 2015, 36(45): 3182-3188. doi: 10.1093/eurheartj/ehv452 pmid: 26400825
[9]	Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med, 2009, 360(3): 213-224. doi: 10.1056/NEJMoa0807611 URL
[10]	de Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J]. N Engl J Med, 2012, 367(11): 991-1001. doi: 10.1056/NEJMoa1205361 URL
[11]	Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis[J]. Circulation, 2009, 120(15): 1505-1512. doi: 10.1161/CIRCULATIONAHA.109.850073 URL
[12]	Jasti V, Ivan E, Yalamanchili V, et al. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis[J]. Circulation, 2004, 110(18): 2831-2836. pmid: 15492302
[13]	de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study[J]. J Am Coll Cardiol, 2011, 58(4): 351-358. doi: 10.1016/j.jacc.2011.02.064 pmid: 21757111
[14]	Kang SJ, Lee JY, Ahn JM, et al. Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease[J]. JACC Cardiovasc Interv, 2011, 4(11): 1168-1174. doi: 10.1016/j.jcin.2011.08.009 URL
[15]	Park SJ, Ahn JM, Kang SJ, et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis[J]. JACC Cardiovasc Interv, 2014, 7(8): 868-874. doi: 10.1016/j.jcin.2014.02.015 URL
[16]	Modi BN, van de Hoef TP, Piek JJ, et al. Physiological assessment of left main coronary artery disease[J]. EuroIntervention, 2017, 13(7): 820-827. doi: 10.4244/EIJ-D-17-00135 URL
[17]	Nascimento BR, de Sousa MR, Koo BK, et al. Diagnostic accuracy of intravascular ultrasound-derived minimal lumen area compared with fractional flow reserve-meta-analysis: pooled accuracy of IVUS luminal area versus FFR[J]. Catheter Cardiovasc Interv, 2014, 84(3): 377-385. doi: 10.1002/ccd.25047 URL
[18]	Johnson TW, Räber L, di Mario C, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions[J]. Eur Heart J, 2019, 40(31): 2566-2584. doi: 10.1093/eurheartj/ehz332 pmid: 31112213
[19]	Oviedo C, Maehara A, Mintz GS, et al. Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible[J]?. Am J Cardiol, 2010, 105(7): 948-954. doi: 10.1016/j.amjcard.2009.11.029 URL
[20]	Oviedo C, Maehara A, Mintz GS, et al. Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located[J]?. Circ Cardiovasc Interv, 2010, 3(2): 105-112. doi: 10.1161/CIRCINTERVENTIONS.109.906016 URL
[21]	Kang SJ, Ahn JM, Kim WJ, et al. Functional and morphological assessment of side branch after left main coronary artery bifurcation stenting with cross-over technique[J]. Catheter Cardiovasc Interv, 2014, 83(4): 545-552. doi: 10.1002/ccd.25057 URL
[22]	Sato K, Naganuma T, Costopoulos C, et al. Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions[J]. Cardiovasc Revasc Med, 2014, 15(2): 80-85. doi: 10.1016/j.carrev.2014.01.014 URL
[23]	Barbato E, Carrié D, Dardas P, et al. European expert consensus on rotational atherectomy[J]. EuroIntervention, 2015, 11(1): 30-36. doi: 10.4244/EIJV11I1A6 URL
[24]	Kang SJ, Ahn JM, Song H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease[J]. Circ Cardiovasc Interv, 2011, 4(6): 562-569. doi: 10.1161/CIRCINTERVENTIONS.111.964643 URL
[25]	Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial[J]. J Am Coll Cardiol, 2004, 43(11): 1959-1963. doi: 10.1016/j.jacc.2004.01.044 URL
[27]	Song HG, Kang SJ, Ahn JM, et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation[J]. Catheter Cardiovasc Interv, 2014, 83(6): 873-878. doi: 10.1002/ccd.24560 URL
[28]	Räber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions[J]. Eur Heart J, 2018, 39(35): 3281-3300. doi: 10.1093/eurheartj/ehy285 URL
[29]	Liu J, Maehara A, Mintz GS, et al. An integrated TAXUS Ⅳ, Ⅴ, and Ⅵ intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents[J]. Am J Cardiol, 2009, 103(4): 501-601. doi: 10.1016/j.amjcard.2008.10.010 URL
[30]	Maehara A, Mintz GS, Stone GW. IVUS guidance during left main PCI: not if, but when and how[J]. EuroIntervention, 2020, 16(3): 189-191. doi: EIJV16I3A32 pmid: 32597762
[31]	de la Torre Hernandez JM, Garcia Camarero T, Baz Alonso JA, et al. Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting[J]. EuroIntervention, 2020, 16(3): 210-217. doi: EIJ-D-19-01057 pmid: 32011286
[32]	Ladwiniec A, Walsh SJ, Holm NR, et al. Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy[J]. EuroIntervention, 2020, 16(3): 201-209. doi: EIJ-D-19-01003 pmid: 32122821
[33]	Tan Q, Wang Q, Liu D, et al. Intravascular ultrasound-guided unprotected left main coronary artery stenting in the elderly[J]. Saudi Med J, 2015, 36(5): 549-553. doi: 10.15537/smj.2015.5.11251 URL
[34]	Park SJ, Kim YH, Park DW, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis[J]. Circ Cardiovasc Interv, 2009, 2(3): 167-177. doi: 10.1161/CIRCINTERVENTIONS.108.799494 URL
[35]	Ye Y, Yang M, Zhang S, et al. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound[J]. PLoS One, 2017, 12(6): e0179756. doi: 10.1371/journal.pone.0179756 URL
[36]	de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries[J]. JACC Cardiovasc Interv, 2014, 7(3): 244-254. doi: 10.1016/j.jcin.2013.09.014 URL
[37]	Kinnaird T, Johnson T, Anderson R, et al. Intravascular imaging and 12-month mortality after unprotected left main stem PCI[J]. JACC Cardiovasc Interv, 2020, 13(3): 346-357. doi: 10.1016/j.jcin.2019.10.007 URL
[38]	Xu B, Redfors B, Yang Y, et al. Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention[J]. JACC Cardiovasc Interv, 2016, 9(20): 2086-2093. doi: 10.1016/j.jcin.2016.08.011 URL
[39]	Liu XM, Yang ZM, Liu XK, et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions[J]. Anatol J Cardiol, 2019, 21(2): 83-90.
[40]	Inaba S, Weisz G, Kobayashi N, et al. Prevalence and anatomical features of acute longitudinal stent deformation: an intravascular ultrasound study[J]. Catheter Cardiovasc Interv, 2014, 84(3): 388-396. doi: 10.1002/ccd.25411 URL
[41]	Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv, 2012, 79(3): 453-495. doi: 10.1002/ccd.23438 URL
[42]	中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016, 44(5): 382-400.
[43]	Ge Z, Kan J, Gao XF, et al. Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH Ⅷ trial[J]. Am Heart J, 2021, 234: 101-110. doi: 10.1016/j.ahj.2021.01.011 URL

血管内超声指导冠状动脉左主干介入治疗

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 43

相关文章 15

编辑推荐

Metrics

本文评价

[1]	胡健, 杨震坤, 闫小响, 杜润, 丁风华, 刘俊. 经皮冠状动脉介入术和冠状动脉旁路移植术对80岁以上左前支慢性闭塞患者的疗效比较[J]. 内科理论与实践, 2022, 17(01): 70-72.
[2]	徐浩, 张治, 解学乾, 杨文艺, 刘少稳. 冠脉生理功能评估软件（DEEPVESSEL FFR）与有创FFR在评估冠脉缺血中的对比研究[J]. 诊断学理论与实践, 2021, 20(04): 384-390.
[3]	杨文洁, 严福华. 2020年版《冠状动脉CT血流储备分数应用中国专家建议》解读[J]. 诊断学理论与实践, 2021, 20(03): 239-244.
[4]	陆浩, 葛雷. 慢性完全闭塞病变介入治疗临床研究进展[J]. 内科理论与实践, 2021, 16(03): 145-150.
[5]	王墨扬, 陈阳, 叶蕴青, 张洪亮, 吴永健. 主动脉瓣狭窄合并冠心病患者的经导管主动脉瓣置换联合介入治疗[J]. 内科理论与实践, 2021, 16(03): 151-154.
[6]	刘晓丽, 马晓腾. CYP2C19基因型与冠心病精准抗血小板治疗[J]. 内科理论与实践, 2021, 16(03): 161-166.
[7]	汤宝鹏,. 皮下植入型心律转复除颤器治疗现状[J]. 内科理论与实践, 2018, 13(01): 15-19.
[8]	胡健, 张瑞岩, 杨震坤, 丁风华, 沈卫峰,. 血管内超声在无保护左主干病变介入治疗中的应用[J]. 内科理论与实践, 2017, 12(02): 120-122.
[9]	胡健, 张瑞岩, 杨震坤, 丁风华, 沈卫峰,. 介入治疗和冠状动脉旁路移植术对高龄无保护左主干病变患者的疗效比较[J]. 内科理论与实践, 2017, 12(01): 46-49.
[10]	蒋米尔, 殷敏毅,. 重症下肢缺血的诊治现状与进展[J]. 外科理论与实践, 2013, 18(05): 405-408.
[11]	席锐, 顾刚, 陶蓉,. 经皮冠状动脉介入治疗患者围手术期TnI升高的相关因素分析[J]. 诊断学理论与实践, 2013, 12(02): 175-178.
[12]	何清, 何奔,. 肾动脉狭窄的诊断和治疗进展[J]. 内科理论与实践, 2009, 4(06): 511-513.
[13]	何奔, 龚兴荣,. 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在直接经皮冠状动脉介入治疗中的应用[J]. 内科理论与实践, 2009, 4(03): 234-235.
[14]	胡大一, 孙艺红,. 重视和规范心肌梗死患者的血运重建治疗[J]. 内科理论与实践, 2009, 4(03): 161-163.
[15]	张娴, 戴嘉,. 经皮冠状动脉介入治疗术后ST段回落对急性心肌梗死预后的影响[J]. 内科理论与实践, 2009, 4(03): 212-213.